Regeneron Pharmaceuticals, Inc. (REGN) Ownership

$792.16

$1.37 (-0.17%)
Last update: 08:10 PM EST
Day's range
$786.79
Day's range
$797

Regeneron Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 9.08 M $7.00 B   0.30% 8.82%
BLACKROCK, INC. 02/12/2026 8.74 M $6,747.12 B   -1.09% 8.49%
STATE STREET CORP 02/13/2026 4.66 M $3.60 B   -0.65% 4.53%
JPMORGAN CHASE & CO 02/11/2026 3.94 M $3.04 B   -3.25% 3.77%
FRANKLIN RESOURCES INC 02/11/2026 2.56 M $1.98 B   4.36% 2.49%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.52 M $1.94 B   -0.65% 2.45%
NUVEEN, LLC 02/12/2026 2.01 M $1,551.86 B   71.07% 1.95%
LOOMIS SAYLES & CO L P 02/12/2026 1.93 M $1.49 B   -2.28% 1.88%
CAPITAL WORLD INVESTORS 02/11/2026 1.40 M $1.08 B   -30.04% 1.36%
MORGAN STANLEY 02/13/2026 1.39 M $1,072.38 B   -4.25% 1.35%
NORGES BANK 02/10/2026 1.31 M $1.01 B   100.00% 1.27%
BANK OF AMERICA CORP /DE/ 02/17/2026 1.16 M $893.38 B   0.30% 1.12%
GOLDMAN SACHS GROUP INC 02/10/2026 1.10 M $846.82 M   15.14% 1.07%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 995.71 K $768.52 M   38.03% 0.95%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 778.00 K $600.52 M   2.97% 0.74%
BANK OF NEW YORK MELLON CORP 02/10/2026 764.24 K $589.90 M   13.79% 0.74%
DEUTSCHE BANK AG\ 02/11/2026 763.93 K $589.65 M   9.65% 0.73%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 745.23 K $575.22 M   0.14% 0.72%
LEGAL & GENERAL GROUP PLC 02/09/2026 743.03 K $573.52 M   -3.55% 0.72%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 639.60 K $493.69 M   2.47% 0.61%
TWO SIGMA ADVISERS, LP 02/17/2026 604.54 K $466.63 M   -34.73% 0.59%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 610.50 K $471.23 M   -7.26% 0.58%
JANE STREET GROUP, LLC 02/12/2026 516.20 K $398.44 B   15.82% 0.50%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 499.54 K $385.59 M   0.09% 0.49%
MARSHALL WACE, LLP 02/13/2026 478.55 K $369.38 M   23.69% 0.47%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 445.80 K $344.05 M   -23.73% 0.43%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 440.84 K $340.27 M   -7.71% 0.43%
NEUBERGER BERMAN GROUP LLC 02/13/2026 422.13 K $325.83 M   1.54% 0.40%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/13/2026 421.23 K $325.26 M   10.55% 0.40%
CENTIVA CAPITAL, LP 02/13/2026 407.10 K $314.23 M   1.78% 0.39%
TD ASSET MANAGEMENT INC 02/10/2026 397.55 K $306.86 M   6.22% 0.39%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 367.87 K $284.72 M   13.76% 0.36%
NATIONAL PENSION SERVICE 02/10/2026 360.99 K $278.64 M   29.79% 0.35%
ROYAL BANK OF CANADA 02/17/2026 345.22 K $266.47 M   -7.47% 0.33%
BARCLAYS PLC 02/13/2026 311.17 K $240.18 B   -4.53% 0.30%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 294.05 K $226.76 M   130.56% 0.29%
SWISS NATIONAL BANK 02/12/2026 285.46 K $220.34 M   -6.71% 0.28%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 01/23/2026 285.03 K $220.01 M   -7.24% 0.28%
EPOCH INVESTMENT PARTNERS, INC. 02/13/2026 281.34 K $217.15 M   8.56% 0.27%
UBS GROUP AG 01/29/2026 271.16 K $209.30 B   -20.13% 0.26%
CITADEL ADVISORS LLC 02/17/2026 274.00 K $211.49 M   66.36% 0.26%
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 01/23/2026 261.85 K $202.11 M   116.61% 0.25%
CITADEL ADVISORS LLC 02/17/2026 265.30 K $204.78 M   27.00% 0.25%
FEDERATED HERMES, INC. 02/12/2026 246.62 K $190.36 M   4.41% 0.24%
CITIGROUP INC 02/13/2026 245.34 K $189.37 M   77.53% 0.23%
ASSENAGON ASSET MANAGEMENT S.A. 01/09/2026 233.23 K $180.02 M   -51.19% 0.23%
SWEDBANK AB 02/09/2026 227.78 K $175.82 M   9.84% 0.22%
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. 02/03/2026 224.86 K $174.56 M   4.02% 0.22%
DEKABANK DEUTSCHE GIROZENTRALE 01/28/2026 211.21 K $206.79 M   0.00% 0.21%
MCDONALD CAPITAL INVESTORS INC/CA 01/30/2026 208.24 K $160.73 M   -2.39% 0.20%

Regeneron Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 1661 institutional investors and hedge funds held shares of Regeneron Pharmaceuticals, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 9.08 M

BlackRock, Inc.: 8.74 M

STATE STREET CORP: 4.66 M

JPMORGAN CHASE & CO: 3.94 M

FRANKLIN RESOURCES INC: 2.56 M

GEODE CAPITAL MANAGEMENT, LLC: 2.52 M

47.65% of Regeneron Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 91.12 M shares in the last 24 months. This purchase volume represents approximately $72.18 B in transactions.